Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
---|---|
Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
ClinicalTrials.gov Identifier: | NCT00000561 |
To determine if dual chamber rate-modulated pacing (DDDR) in patients with sick sinus syndrome is superior to single chamber pacing (VVIR) with respect to subsequent frequency of adverse clinical events such as stroke, quality of life and function, and cost effectiveness.
Condition | Intervention | Phase |
---|---|---|
Arrhythmia Cardiovascular Diseases Heart Diseases Sick Sinus Syndrome Vascular Diseases Cerebrovascular Accident |
Device: pacemaker, artificial |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Men and women with sick sinus syndrome.
Study ID Numbers: | 105 |
Study First Received: | October 27, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00000561 |
Health Authority: | United States: Federal Government |
Heart Diseases Cerebral Infarction Arrhythmia, Sinus Stroke Vascular Diseases Central Nervous System Diseases Ischemia Brain Diseases |
Cerebrovascular Disorders Heart Block Brain Ischemia Brain Infarction Sick Sinus Syndrome Infarction Arrhythmias, Cardiac |
Disease Pathologic Processes Syndrome Nervous System Diseases Cardiovascular Diseases |